Michael J. Zeléfsky
About
Michael J. Zeléfsky is a scholar working on Pulmonary and Respiratory Medicine, Radiation and Surgery.
According to data from OpenAlex, Michael J. Zeléfsky has authored 544 papers receiving a total of 29.3k indexed citations (citations by other indexed papers that have themselves been cited), including 417 papers in Pulmonary and Respiratory Medicine, 263 papers in Radiation and 117 papers in Surgery. Recurrent topics in Michael J. Zeléfsky's work include Prostate Cancer Diagnosis and Treatment (324 papers), Prostate Cancer Treatment and Research (274 papers) and Advanced Radiotherapy Techniques (263 papers). Michael J. Zeléfsky is often cited by papers focused on Prostate Cancer Diagnosis and Treatment (324 papers), Prostate Cancer Treatment and Research (274 papers) and Advanced Radiotherapy Techniques (263 papers). Michael J. Zeléfsky collaborates with scholars based in United States, Canada and Germany. Michael J. Zeléfsky's co-authors include Zvi Fuks, Steven A. Leibel, Yoshiya Yamada, Margie Hunt, Marisa Kollmeier, Ennapadam Venkatraman, Xin Pei, Dennis H. Kraus, Andrew Jackson and Chandra Burman and has published in prestigious journals such as Journal of Clinical Oncology, Cancer and Annals of Surgery.
In The Last Decade
Michael J. Zeléfsky
527 papers receiving 28.7k citations
Hit Papers
Peers — A (Enhanced Table)
Peers by citation overlap · career bar shows stage (early→late) cites · hero ref
| Name | h | Career | Trend | Papers | Cites | |||||
|---|---|---|---|---|---|---|---|---|---|---|
| Michael J. Zeléfsky United States | 92 | 21.5k | 12.5k | 6.6k | 6.2k | 4.0k | 544 | 29.3k | ||
| M. Bolla France | 50 | 16.6k 0.8× | 3.3k 0.3× | 5.1k 0.8× | 3.2k 0.5× | 4.6k 1.1× | 231 | 22.9k | ||
| Steven A. Leibel United States | 71 | 11.1k 0.5× | 8.5k 0.7× | 2.8k 0.4× | 6.0k 1.0× | 1.7k 0.4× | 208 | 17.1k | ||
| Padraig Warde Canada | 61 | 9.7k 0.5× | 3.4k 0.3× | 5.1k 0.8× | 2.2k 0.4× | 3.2k 0.8× | 420 | 16.2k | ||
| Howard D. Thames United States | 65 | 8.6k 0.4× | 5.0k 0.4× | 2.9k 0.4× | 5.3k 0.9× | 3.2k 0.8× | 298 | 16.4k | ||
| Lawrence B. Marks United States | 73 | 11.8k 0.5× | 9.9k 0.8× | 3.6k 0.5× | 10.1k 1.6× | 4.8k 1.2× | 471 | 24.0k | ||
| David P. Dearnaley United Kingdom | 73 | 11.3k 0.5× | 4.6k 0.4× | 4.3k 0.6× | 5.0k 0.8× | 3.7k 0.9× | 416 | 18.4k | ||
| Johannes A. Langendijk Netherlands | 76 | 10.2k 0.5× | 5.8k 0.5× | 5.4k 0.8× | 5.9k 0.9× | 4.6k 1.1× | 642 | 21.8k | ||
| Gerald E. Hanks United States | 76 | 13.9k 0.6× | 6.6k 0.5× | 3.9k 0.6× | 3.3k 0.5× | 2.2k 0.6× | 393 | 19.4k | ||
| Benjamin Movsas United States | 63 | 8.8k 0.4× | 4.8k 0.4× | 2.7k 0.4× | 4.3k 0.7× | 4.0k 1.0× | 478 | 15.5k | ||
| Alvaro A. Martinez United States | 75 | 9.3k 0.4× | 9.9k 0.8× | 2.8k 0.4× | 5.4k 0.9× | 1.9k 0.5× | 393 | 17.2k |
Countries citing papers authored by Michael J. Zeléfsky
Since
Specialization
Citations
This map shows the geographic impact of Michael J. Zeléfsky's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michael J. Zeléfsky with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michael J. Zeléfsky more than expected).
Fields of papers citing papers by Michael J. Zeléfsky
Since
Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences
This network shows the impact of papers produced by Michael J. Zeléfsky. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michael J. Zeléfsky. The network helps show where Michael J. Zeléfsky may publish in the future.
Co-authorship network of co-authors of Michael J. Zeléfsky
This figure shows the co-authorship network connecting the top 25 collaborators of Michael J. Zeléfsky. A scholar is included among the top collaborators of Michael J. Zeléfsky based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Michael J. Zeléfsky. Michael J. Zeléfsky is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
1.
Woo, Sungmin, D. Freedman, Anton S. Becker, et al.. (2024). Equivocal bone lesions on PSMA PET/CT: systematic review and meta-analysis on their prevalence and malignancy rate. Clinical and Translational Imaging. 12(5). 485–500.
2.
Imber, Brandon S., Lisa Bodei, John L. Humm, et al.. (2023). A Pilot Study of Stereotactic Body Radiotherapy and 177Lu-PSMA-617 for Oligometastatic Hormone Sensitive Prostate Cancer. International Journal of Radiation Oncology*Biology*Physics. 117(2). e112–e112.
3.
Gewanter, Richard M., Jaspreet S. Sandhu, Amy L. Tin, et al.. (2023). Assessment of Patients With Prostate Cancer and Their Understanding of the International Prostate Symptom Score Questionnaire. Advances in Radiation Oncology. 8(4). 101200–101200.
4.
Jiang, Jue, et al.. (2023). Deep learning‐based dominant index lesion segmentation for MR‐guided radiation therapy of prostate cancer. Medical Physics. 50(8). 4854–4870.
5.
Happersett, Laura, et al.. (2023). Reduction of Late Urinary Toxicity from Prostate Cancer Radiotherapy via Intrafractional MV-kV Image Guidance. International Journal of Radiation Oncology*Biology*Physics. 117(2). S49–S49.
6.
Zeléfsky, Michael J., Debra A. Goldman, Sean M. McBride, et al.. (2021). Predictors for post-treatment biopsy outcomes after prostate stereotactic body radiotherapy. Radiotherapy and Oncology. 159. 33–38.
7.
Zeléfsky, Michael J., Marisa Kollmeier, Sean M. McBride, et al.. (2019). Five-Year Outcomes of a Phase 1 Dose-Escalation Study Using Stereotactic Body Radiosurgery for Patients With Low-Risk and Intermediate-Risk Prostate Cancer. International Journal of Radiation Oncology*Biology*Physics. 104(1). 42–49.
8.
Zakian, Kristen L., Andreas G. Wibmer, Hebert Alberto Vargas, et al.. (2019). Comparison of Motion-Insensitive T2-Weighted MRI Pulse Sequences for Visualization of the Prostatic Urethra During MR Simulation. Practical Radiation Oncology. 9(6). e534–e540.
9.
Yamada, Yoshiya, Evangelia Katsoulakis, Ilya Laufer, et al.. (2017). The impact of histology and delivered dose on local control of spinal metastases treated with stereotactic radiosurgery. Neurosurgical FOCUS. 42(1). E6–E6.
10.
Lis, Eric, Kyung K. Peck, J. Zatcky, et al.. (2017). Dynamic contrast-enhanced magnetic resonance imaging of osseous spine metastasis before and 1 hour after high-dose image-guided radiation therapy. Neurosurgical FOCUS. 42(1). E9–E9.
11.
Hunt, Margie, Hai Pham, Rajesh Regmi, et al.. (2016). Simultaneous MV‐kV imaging for intrafractional motion management during volumetric‐modulated arc therapy delivery*. Journal of Applied Clinical Medical Physics. 17(2). 473–486.
12.
Zeléfsky, Michael J., Marisa Kollmeier, Brett Cox, Sean M. McBride, & Laura Happersett. (2016). Early Results of a Phase I Dose Escalation Study Using Stereotactic Body Radiosurgery for Patients with Clinically Localized Prostate Cancer. Cureus. 8(6).
13.
Spratt, Daniel E. & Michael J. Zeléfsky. (2013). Point: There is a need for supplemental XRT with brachytherapy in the treatment of intermediate-risk prostate cancer patients. Brachytherapy. 12(5). 389–392.
14.
Polkinghorn, William R. & Michael J. Zeléfsky. (2013). Improving outcomes in high-risk prostate cancer with radiotherapy. Reports of Practical Oncology & Radiotherapy. 18(6). 333–337.
15.
Zeléfsky, Michael J., Xin Pei, Joanne F. Chou, et al.. (2011). Dose Escalation for Prostate Cancer Radiotherapy: Predictors of Long-Term Biochemical Tumor Control and Distant Metastases–Free Survival Outcomes. European Urology. 60(6). 1133–1139.
16.
Bakst, Richard L., Nancy Lee, David G. Pfister, et al.. (2010). Hypofractionated Dose-Painting Intensity Modulated Radiation Therapy With Chemotherapy for Nasopharyngeal Carcinoma: A Prospective Trial. International Journal of Radiation Oncology*Biology*Physics. 80(1). 148–153.
17.
Setton, Jeremy, N. Caria, Jonathan Romanyshyn, et al.. (2010). Intensity-Modulated Radiotherapy in the Treatment of Oropharyngeal Cancer: An Update of the Memorial Sloan-Kettering Cancer Center Experience. International Journal of Radiation Oncology*Biology*Physics. 82(1). 291–298.
18.
Zeléfsky, Michael J., Emily J. Levin, Margie Hunt, et al.. (2008). Incidence of Late Rectal and Urinary Toxicities After Three-Dimensional Conformal Radiotherapy and Intensity-Modulated Radiotherapy for Localized Prostate Cancer. International Journal of Radiation Oncology*Biology*Physics. 70(4). 1124–1129.
19.
Leibel, Steven A., Zvi Fuks, Michael J. Zeléfsky, & W.F. Whitmore. (1994). The effects of local and regional treatment on the metastatic outcome in prostatic carcinoma with pelvic lymph node involvement. International Journal of Radiation Oncology*Biology*Physics. 28(1). 7–16.
20.
Zeléfsky, Michael J., Steven A. Leibel, Chandra Burman, et al.. (1994). Neoadjuvant hormonal therapy improves the therapeutic ratio in patients with bulky prostatic cancer treated with three-dimensional conformal radiation therapy. International Journal of Radiation Oncology*Biology*Physics. 29(4). 755–761.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.
Explore authors with similar magnitude of impact
Breakdown of academic impact, for papers by M. Bolla Breakdown of academic impact, for papers by Steven A. Leibel Breakdown of academic impact, for papers by Padraig Warde Breakdown of academic impact, for papers by Howard D. Thames Breakdown of academic impact, for papers by Lawrence B. Marks Breakdown of academic impact, for papers by David P. Dearnaley Breakdown of academic impact, for papers by Johannes A. Langendijk Breakdown of academic impact, for papers by Gerald E. Hanks Breakdown of academic impact, for papers by Benjamin Movsas Breakdown of academic impact, for papers by Alvaro A. Martinez